Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of American Academy of Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaad.2016.02.1239PMID 27986133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

  2016cited by this paper
• Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

  2016cited by this paper
• Stress Dose Steroids: Myths and Perioperative Medicine

  2016cited by this paper
• Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis

  2014cited by this paper
• Proton pump inhibitor therapy and potential long-term harm

  2014cited by this paper
• Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.

  2013cited by this paper
• [Concomitant use of proton pump inhibitors and systemic corticosteroids].

  2013cited by this paper
• Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself.

  2013cited by this paper
• Recent safety concerns with proton pump inhibitors.

  2012cited by this paper
• Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD.

  2011cited by this paper
• Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications

  2011cited by this paper
• Adrenal insufficiency: etiology, diagnosis and treatment

  2010cited by this paper
• Evidenzbasierte EULAR-Empfehlungen zum Management einer systemischen Glukokortikoid-Therapie bei rheumatischen Erkrankungen

  2009cited by this paper
• Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease

  2008cited by this paper
• Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice

  2008cited by this paper
• Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

  2008cited by this paper
• Corticosteroid physiology and principles of therapy

  2008cited by this paper
• Dose-related patterns of glucocorticoid-induced side effects

  2008cited by this paper
• EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

  2007cited by this paper
• Glucocorticoid-Induced Diabetes Mellitus: Prevalence and Risk Factors in Primary Renal Diseases

  2006cited by this paper
• Editorial: glucocorticoid replacement--how much is enough?

  2006cited by this paper
• Glucocorticoid Replacement—How Much Is Enough?

  2006cited by this paper
• Exogenous Cushing's syndrome and glucocorticoid withdrawal.

  2005influential reference
• Systemic lupus erythematosus and acute pancreatitis: a case series

  2004cited by this paper
• Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review.

  2002cited by this paper
• Steroids and risk of upper gastrointestinal complications.

  2001cited by this paper
• Corticosteroid withdrawal

  1998cited by this paper
• Diabetes management in special situations.

  1997cited by this paper
• Glucocorticoids and the risk for initiation of hypoglycemic therapy.

  1994cited by this paper
• Corticosteroids and peptic ulcer: meta‐analysis of adverse events during steroid therapy

  1994influential reference
• Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial.

  1993influential reference
• The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone

  1992cited by this paper
• Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs.

  1991cited by this paper
• Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

  1991cited by this paper
• Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry.

  1991cited by this paper
• Alternate day corticosteroid causes alternate day hyperglycaemia.

  1987cited by this paper
• Association of adrenocorticosteroid therapy and peptic-ulcer disease.

  1983cited by this paper
• Alternate-day corticosteroid therapy.

  1978cited by this paper
• Adrenocortical responsiveness after alternate-day corticosteroid therapy.

  1968cited by this paper
• Clinical Features of the Diabetic Syndrome Appearing after Steroid Therapy

  1964cited by this paper

• Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication

  2026cites this paper
• International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Disease

  2025cites this paper
• Safe Use of Corticosteroids in Non-Infectious Uveitis

  2025cites this paper
• Metabolite profiling and bioactivity of Pogostemon cablin L. from North Konawe: GC-MS analysis, anti-inflammatory, and antinociceptive mechanisms via COX-2/cytokine inhibition

  2025cites this paper
• Gastrointestinal symptoms are common in patients with new-onset refractory status epilepticus (NORSE)

  2025cites this paper
• Unveiling Gastrointestinal Involvement in Hypopituitarism: Clinical Features and Treatment Approaches

  2025cites this paper
• Development and Validation of a Patient-Reported Outcome Measure to Assess the Impact of Steroids in the Treatment of Myeloma: The Steroid Symptom Questionnaire-Multiple Myeloma.

  2025cites this paper
• An alkali-extracted acidic heteropolysaccharide from Portulaca oleracea L. ameliorates acute lung injury in septic mice by inhibiting macrophage pyroptosis.

  2025cites this paper
• Glucocorticoid Receptor Inhibits the Progression of Schistosomiasis Hepatic Fibrosis Through Inducing Circadian Clock Gene Per1.

  2025cites this paper
• Antibacterial antioxidant polyurethane/curcumin patch with anti-swelling ability for tissue adhesion and treatment of oral ulcers

  2025cites this paper
• Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis

  2025cites this paper
• Update on Medical Management of Acute Peripheral Facial Palsy

  2025cites this paper
• Propolis suppresses atopic dermatitis through targeting the MKK4 pathway

  2024cites this paper
• Efeitos adversos da corticoterapia sistêmica crônica: o que o dermatologista deve saber

  2024cites this paper
• II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata

  2024cites this paper
• Prophylactic Proton Pump Inhibitors in Upper Gastrointestinal Bleeding: Impact and Underprescription in a French Multicentric Cohort

  2024cites this paper
• Current status and influencing factors of prophylactic use of proton pump inhibitors in internal medicine inpatients receiving glucocorticoid therapy

  2024cites this paper
• Redox-sensitive disulfide-bridged self-assembled nanoparticles of dexamethasone with high drug loading for acute lung injury therapy.

  2024cites this paper
• PREVALENCE, SURGICAL MANAGEMENT, AND OUTCOME OF PERFORATION OF THE GASTER ASSOCIATED WITH LONG TERM CORTICOSTEROID USE : A COMPREHENSIVE SYSTEMATIC REVIEW

  2024cites this paper
• Beclomethasone loaded liposomes enriched with mucin: A suitable approach for the control of skin disorders.

  2024cites this paper
• Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP

  2024cites this paper
• The hidden dangers of short-term glucocorticoid use in children: A genomic analysis.

  2024cites this paper
• The Effect of Lepidium Sativum L. Extract Loaded on Chitosan Nanoparticles in Experimental Rat Model of Osteoporosis

  2024cites this paper
• Anticancer drug-induced interstitial lung disease: a critical appraisal of clinical practice guidelines and consensus statements.

  2024cites this paper
• Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults

  2024cites this paper
• Treatment Options in Pediatric Behçet’s Disease

  2023cites this paper
• Liposomal form of Dexamethasone in Experimental Autoimmune Uveitis: Clinical and Immunological Effects

  2023cites this paper
• Cellular Immunobiology and Molecular Mechanisms in Alloimmunity—Pathways of Immunosuppression

  2023cites this paper
• DEXAMETHASONE AS ADJUVANT TO ROPIVACAINE IN WOUND INFILTRATION FOR POSTOPERATIVE ANALGESIA FOLLOWING SPINAL SURGERY: A RANDOMIZED, DOUBLE-BLINDED, CONTROLLED TRIAL

  2023cites this paper
• Trends and Patterns of Systemic Glucocorticoid Prescription in Primary Care Institutions in Southwest China, from 2018 to 2021

  2023cites this paper
• Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper

  2023cites this paper
• Balancing inflammation and adverse effects of glucocorticoids in clinical practice

  2023cites this paper
• Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know

  2023cites this paper
• N-Acetylglucosamine mitigates lung injury and pulmonary fibrosis induced by bleomycin.

  2023cites this paper
• Layered Double Hydroxides: A Novel Promising 2D Nanomaterial for Bone Diseases Treatment

  2023cites this paper
• The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

  2022cites this paper
• Upper gastrointestinal system bleedings in COVID-19 patients: Risk factors and management/a retrospective cohort study

  2022cites this paper
• Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.

  2022cites this paper
• Anticoagulants and corticosteroids in COVID-19: What do we know so far?

  2022influential citation
• Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study

  2022cites this paper
• Systematic review—pancreatic involvement in inflammatory bowel disease

  2022cites this paper
• The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy

  2022cites this paper
• Clinical effectiveness of short course oral prednisone for stricture prevention after semi-circumferential esophageal endoscopic submucosal dissection

  2022cites this paper
• Neuroendocrine–Immune Regulatory Network of Eucommia ulmoides Oliver

  2022cites this paper
• Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis

  2022cites this paper
• Chinese National Consensus Committee of Experts on Kawasaki Disease and Chinese Journal of Contemporary Pediatrics: The expert consensuses on Intravenous Immunoglobulin, aspirin, and Glucocorticoid

  2022cites this paper
• Corticosteroids in oncology: use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper.

  2022influential citation
• Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management

  2022cites this paper
• Treatment of cutaneous vasculitis

  2022cites this paper
• Pre-Emptive Incision-Site Infiltration with Ropivacaine Plus Dexamethasone for Postoperative Pain After Supratentorial Craniotomy: A Prospective Randomized Controlled Trial

  2021cites this paper
• Pancreatic Disorders in Patients with Inflammatory Bowel Disease

  2021cites this paper
• Vaccination in pediatric acquired inflammatory immune-mediated neuromuscular disorders.

  2021cites this paper
• Efectos adversos de la terapia con glucocorticoides

  2021cites this paper
• Drugs for the Skinternist

  2021cites this paper
• Effect of Lactobacillus fermentum TKSN041 on improving streptozotocin-induced type 2 diabetes in rats.

  2021cites this paper
• Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology

  2021cites this paper
• Systemic Corticosteroids

  2021cites this paper
• A Risk Prediction Model for Prolonged Length of Stay in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Study of 225 Patients in a Single Center in Kunming, China

  2021cites this paper
• Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies.

  2021cites this paper
• Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases

  2021cites this paper
• Susac syndrome: challenges in the diagnosis and treatment.

  2021cites this paper
• Effect of Intermittent Fasting on Glucose Homeostasis and Bone Remodeling in Glucocorticoid-Induced Osteoporosis Rat Model

  2021cites this paper
• Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents

  2021cites this paper
• Review of dexamethasone administration for management of complications in postoperative third molar surgery

  2021cites this paper
• Management of Cutaneous Vasculitis.

  2020cites this paper
• Autoimmune bullous skin diseases, pemphigus and pemphigoid.

  2020cites this paper
• Complicaciones gastroduodenales de los tratamientos farmacológicos

  2020cites this paper
• Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016

  2020cites this paper
• Consenso sobre tratamento da alopecia areata − Sociedade Brasileira de Dermatologia

  2020cites this paper
• GM6001 improves bone dysfunction and bone metabolism disorder in SINFH rats

  2020cites this paper
• Pharmakologie der CED-Medikamente

  2020cites this paper
• Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology⋆⋆⋆

  2020cites this paper
• The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review

  2020cites this paper
• ANTIULCER ACTIVITY OF 2-PHENYL-9-DIETHYLAMINO-ETHYLIMIDAZO[1,2-A]BENZIMIDAZOLE DINITRATE IN ETHANOL-PREDNISOLONE DAMAGE TO GASTRIC MUCOSA

  2020cites this paper
• Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.

  2020cites this paper
• Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China

  2020cites this paper
• Gastrolesività e steroidi: miti e realtà

  2019cites this paper
• Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open‐label, randomized controlled trial

  2019cites this paper
• Polypharmacy and medication errors on admission to palliative care

  2019cites this paper
• Glucocorticoids

  2019cites this paper
• The effect of prebiotics on intestinal digestion of carbohydrates in lead intoxicated rats

  2019cites this paper
• Cartilage Tissue Engineering: An Update on Multi-Component Approach

  2019cites this paper
• A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology

  2019cites this paper
• Secondary diabetes mellitus in pemphigus vulgaris and management issues

  2019cites this paper
• Epidural dexamethasone injections in diabetic patients under perioperative glycemic control

  2019cites this paper
• Physiologic Steroid Tapering

  2019cites this paper
• Systemic Therapies for Scarring and Non-scarring Alopecia

  2018cites this paper
• Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

  2018cites this paper
• An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).

  2018cites this paper
• Glucocorticoid treatment in juvenile idiopathic arthritis

  2018cites this paper
• Chronisch-entzündliche Darmerkrankungen: Diagnostik und Therapie in der Praxis

  2018influential citation
• Practical Pearls About Current Rheumatic Medications.

  2018cites this paper
• Side effects of medications used to treat childhood interstitial lung disease.

  2018cites this paper
• Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

  2018cites this paper
• Oral systemic agents for immunobullous disorders

  2018cites this paper
• Do glucocorticoids affect the development of ulcers and erosions of the upper gastrointestinal tract in patients taking NSAIDs.

  2018cites this paper
• Clinical considerations of drug management in chronic cardiovascular and respiratory disorders in perioperative healthcare

  2018cites this paper
• Resveratrol Attenuates Microglial Activation via SIRT1-SOCS1 Pathway

  2017cites this paper
• Management of cervicofacial infections: a survey of current practice in maxillofacial units in the UK.

  2017cites this paper
• Anais Brasileiros de Dermatologia

  2004cites this paper